Shares of ResMed Inc. RMD shed 4.58% to $225.79 Tuesday, on what proved to be an all-around rough trading session for the ...
Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.
These shares are having a tough time on hump day. What's happening? The post Why Breville, Flight Centre, Orica, and ResMed ...
Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to EveryoneSAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), ...
StockStory.org on MSN1d
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.
Resmed (RMD) announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers ...
Goldman Sachs analyst Davinthra Thillainathan maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ...
Down, but certainly not out. The post Should you buy this top ASX share in the dip? appeared first on The Motley Fool Australia.
Resmed, Inc.: Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to EveryoneSAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), ...
Shares of ResMed Inc. RMD advanced 3.29% to $232.44 Friday, on what proved to be an all-around positive trading session for ...
13h
Stockhead on MSNHealth Check: Star biotech stocks are going cheap – or cheaper than they wereThe deepening market sell off has not spared many of the big commercialised, profitable biotechs. But the question is whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results